The same analysis among the progressive myeloma precursor conditions and MM (both WGS and WXS) showed that multiple driver genes were under selective pressure, including mutations involving MAPK and NFkB pathways, and tumor suppressor genes such as TP53 (Supplementary Data 3). The gene discussed is NFKB1; the disease is plasma cell myeloma.